share

Neutrophil Elastase Inhibitor CAS NO 1448314-31-5


Unit Price:

CAS No.:1448314-31-5

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Neutrophil Elastase Inhibitor CAS NO 1448314-31-5 is a potent and selective small molecule compound designed to target and inhibit the activity of neutrophil elastase, a key enzyme involved in inflammatory processes. This inhibition is crucial for modulating tissue damage and inflammation in various pathological conditions. It is an essential research tool and a promising candidate for therapeutic development, primarily targeted at pharmaceutical R&D teams, academic researchers, and biotechnology companies focused on inflammatory and respiratory diseases.

Application

  • Pharmaceutical Research & Development: Serves as a key reference standard and active pharmaceutical ingredient (API) in the development of novel therapeutics for neutrophil-driven inflammatory disorders.
  • Biochemical & Mechanistic Studies: Used in in vitro and in vivo models to elucidate the role of neutrophil elastase in disease pathways such as chronic obstructive pulmonary disease (COPD), acute lung injury, and cystic fibrosis.
  • Preclinical Candidate Screening: Employed in high-throughput screening assays to evaluate the efficacy and selectivity of new drug candidates targeting serine proteases.
  • Academic & Institutional Research: A vital reagent for universities and research institutes studying inflammation, immunology, and protease biology.
  • Biomarker & Diagnostic Development: Can be utilized in the development of assays to measure elastase activity or inhibition as a biomarker for disease progression or therapeutic response.

Basic Information

Product Name Neutrophil Elastase Inhibitor
CAS No. 1448314-31-5
Molecular Formula Contact for details
Molecular Weight Contact for details
Synonyms NE Inhibitor; Human Neutrophil Elastase (HNE) Inhibitor; Elastase Inhibitor, Neutrophil; Serine Protease Inhibitor; 1448314-31-5; (Compound code specific to manufacturer); Leukocyte Elastase Inhibitor
EINECS Contact for details

Quality Control

Our Neutrophil Elastase Inhibitor is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including identity confirmation by spectroscopic methods (NMR, MS) and purity assessment by high-performance liquid chromatography (HPLC). We provide full traceability and Certificates of Analysis (COA) are available for every shipment, detailing all critical quality attributes to support your regulatory and research requirements.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as specified on the label or COA. This compound is hygroscopic (moisture-sensitive) and must be kept in a dry environment. For long-term storage, consider desiccation.

Specification

Item Specification
Appearance White to off-white solid
Identification (HPLC/MS) Conforms to reference standard
Identification (NMR) Conforms to structure
Purity (HPLC) ≥95% (Area %)
Water Content (KF) ≤5.0%
Residual Solvents (GC) Complies with ICH guidelines
Biological Activity (IC50) Reported per batch

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.